Cargando…

Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers

BACKGROUND: Recurrence represents a well-known poor prognostic factor for colorectal cancer (CRC) patients. This study aimed to establish an effective prognostic prediction model based on noninvasive circulating tumor DNA methylation markers for CRC patients receiving radical surgery. RESULTS: Two m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xin, Wen, Xiaofeng, Guo, Qin, Zhang, Yunfeng, Liang, Zhenxing, Wu, Qian, Li, Zhihao, Ruan, Weimei, Ye, Zhujia, Wang, Hong, Chen, Zhiwei, Fan, Jian-Bing, Lan, Ping, Liu, Huashan, Wu, Xianrui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714195/ https://www.ncbi.nlm.nih.gov/pubmed/36457093 http://dx.doi.org/10.1186/s13148-022-01383-8

Ejemplares similares

Cyr61 from adipose‐derived stem cells promotes colorectal cancer metastasis and vasculogenic mimicry formation via integrin α(V)β(5)
por: Liang, Zhenxing, et al.
Publicado: (2021)

A novel cell‐free DNA methylation‐based model improves the early detection of colorectal cancer
por: Wu, Xianrui, et al.
Publicado: (2021)

Accurate detection of early-stage lung cancer using a panel of circulating cell-free DNA methylation biomarkers
por: Hu, Shuo, et al.
Publicado: (2023)

Mutant KRAS triggers functional reprogramming of tumor-associated macrophages in colorectal cancer
por: Liu, Huashan, et al.
Publicado: (2021)

Sensitive detection of colorectal cancer in peripheral blood by a novel methylation assay
por: Zhang, Yunfeng, et al.
Publicado: (2021)

Tumor-intrinsic CD47 signal regulates glycolysis and promotes colorectal cancer cell growth and metastasis
por: Hu, Tuo, et al.
Publicado: (2020)

Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case–control study
por: Sui, Jinke, et al.
Publicado: (2021)

Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer
por: Lin, Wu-Hao, et al.
Publicado: (2021)

Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer
por: Philipp, Alexander B, et al.
Publicado: (2014)

m(6)A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways
por: Deng, Ru, et al.
Publicado: (2019)

Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer
por: Varkaris, Andreas, et al.
Publicado: (2019)

Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer
por: Fu, Bo, et al.
Publicado: (2018)

Circulating cell-free DNA-based methylation patterns for breast cancer diagnosis
por: Zhang, Xianyu, et al.
Publicado: (2021)

Pan‐cancer analysis of genome‐wide methylation profiling discover type‐specific markers targeting circulating free DNA for the detection of colorectal cancer
por: Zhang, Lei, et al.
Publicado: (2023)

Blood free-circulating DNA testing by highly sensitive methylation assay to diagnose colorectal neoplasias
por: Suehiro, Yutaka, et al.
Publicado: (2018)

Genome-wide discovery of circulating cell-free DNA methylation biomarkers for colorectal cancer detection
por: Fang, Qingxiao, et al.
Publicado: (2023)

Epigenetic markers in circulating cell‐free DNA as prognostic markers for survival of castration‐resistant prostate cancer patients
por: Hendriks, Rianne J., et al.
Publicado: (2018)

Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis
por: Bossen, Lars, et al.
Publicado: (2021)

Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients
por: Xu, Xiaojing, et al.
Publicado: (2020)

Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer
por: Liu, Qi, et al.
Publicado: (2020)

Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers
por: Punia, Sohan, et al.
Publicado: (2021)

Role of circulating free DNA in colorectal cancer
por: Matikas, Alexios, et al.
Publicado: (2016)

Circulating cell free DNA as the diagnostic marker for colorectal cancer: a systematic review and meta-analysis
por: Wang, Xin, et al.
Publicado: (2018)

Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer
por: Wang, Dong, et al.
Publicado: (2019)

DNA-methylated gene markers for colorectal cancer in TCGA database
por: Zhang, Hui, et al.
Publicado: (2020)

Different primers for diagnosing circulating cell-free DNA of colorectal cancer
por: Shi, Hao, et al.
Publicado: (2020)

A novel DNA methylation signature associated with lymph node metastasis status in early gastric cancer
por: Chen, Shang, et al.
Publicado: (2022)

Rapid and Label-Free Analysis of Antigen–Antibody Dynamic Binding of Tumor Markers Using Piezoelectric Quartz Crystal Biosensor
por: Chen, Yan, et al.
Publicado: (2023)

Dynamic heterogeneity of colorectal cancer during progression revealed clinical risk-associated cell types and regulations in single-cell resolution and spatial context
por: Ke, Haoxian, et al.
Publicado: (2023)

Methylation of cell-free circulating DNA in the diagnosis of cancer
por: Warton, Kristina, et al.
Publicado: (2015)

Incidence and risk factors for incisional surgical site infection in patients with Crohn’s disease undergoing bowel resection
por: Hu, Tuo, et al.
Publicado: (2018)

Molecular Alterations in Circulating Cell-Free DNA in Patients with Colorectal Adenoma or Carcinoma
por: Hu, Ying, et al.
Publicado: (2020)

Detection of Methylated Septin 9 in Tissue and Plasma of Colorectal Patients with Neoplasia and the Relationship to the Amount of Circulating Cell-Free DNA
por: Tóth, Kinga, et al.
Publicado: (2014)

Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature
por: Galanopoulos, Michail, et al.
Publicado: (2017)

High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib
por: Amatu, Alessio, et al.
Publicado: (2019)

The Potential of Circulating Cell-Free DNA Methylation as an Epilepsy Biomarker
por: Martins-Ferreira, Ricardo, et al.
Publicado: (2022)

Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer
por: Xu, Fei, et al.
Publicado: (2021)

DNA Methylation-Based Estimates of Circulating Leukocyte Composition for Predicting Colorectal Cancer Survival: A Prospective Cohort Study
por: Gào, Xīn, et al.
Publicado: (2021)

Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
por: Hao, T B, et al.
Publicado: (2014)

Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ngamjvqei6bhog743q8crk09u3